Surging patient interest in self-managed healthcare delivery models has propelled Digital Therapeutics (DTx) to the forefront of medicine. With an aim to deliver on-demand, personalized and patient-centric care, the healthcare ecosystem is actively integrating DTx across its existing patient care infrastructure.

Zinnov, a leading global management and strategy consulting firm in partnership with HARMAN, a global leader in connected solutions, is hosting an exclusive Virtual Roundtable Discussion on the theme “Digital Therapeutics – Opportunities and Challenges” on 22th April 2021 from 8:00 AM to 9:30 AM PDT / 10:00 AM to 11:30 AM CDT / 11:00 AM to 12:30 PM EDT.

Healthcare stakeholders are increasingly deploying investments towards technologies such as AR/VR, AI/ML, sensors, platforms, etc., and are focusing on developing relevant digital capabilities to build DTx solutions. By providing access to real-world patient data for improved drug efficacy & individualized therapy, better patient engagement, and reduced cost of care, DTx is uniquely positioned to provide meaningful benefits across the spectrum of healthcare stakeholders.

A key factor propelling the adoption of DTx is Partnerships. Join us as we bring together the entire healthcare ecosystem of Providers, Medical Device Manufacturers, Pharmaceuticals and health-tech companies onto the same platform to discuss the evolving use-cases for digital therapeutics along with the implementation and scaling challenges.

Key Discussion Areas

  • What benefits does DTx offer in addition to the current healthcare delivery models?
  • What are the key use-cases that can be enabled / improved through DTx?
  • What are the challenges with respect to adoption and scaling of DTx solutions across the healthcare ecosystem?
  • What role do partnerships play in building a robust DTx solution?
  • What are the best practices that need to be adopted while building DTx solutions?



Janet D

Sr. Clinical Director, Medical and Scientific Affairs

Flatiron Health


Douglas Lee

Vice President, Business Development & Licensing

Bayer AG Pharmaceuticals (DAX: BAYN)


Suresh kumar R

CTO CCS India & Digital Incubators



Sidhant Rastogi

Managing Partner




Note: Fields marked * are mandatory

Registration to the event is subject to the following conditions:

  • Confirmation of participation is at the sole discretion of Zinnov.
  • The Zinnov team will respond within 5 business days of registration, on the status of confirmation.
  • Representatives from Services companies are requested to refrain from registering for the event.